| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.17.4.755 |
| P698 | PubMed publication ID | 9108791 |
| P50 | author | Daniela Mari | Q30093174 |
| Giampiero Merati | Q57054640 | ||
| P2093 | author name string | P M Mannucci | |
| C Franceschi | |||
| E Taioli | |||
| F Peyvandi | |||
| P Sansoni | |||
| S Bertolini | |||
| E Sacchi | |||
| L Tagliabue | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 755-759 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians | |
| P478 | volume | 17 |
| Q46707808 | An Insertion/Deletion polymorphism in the promoter region of the plasminogen activator inhibitor-1 gene is associated with plasma levels but not with stroke risk in the elderly |
| Q73681273 | Angiotensin-Converting Enzyme Gene Polymorphism and Plasminogen Activator Inhibitor 1 Levels in Subjects with Cerebral Infarction |
| Q28768489 | Causes, effects, and constraints in the genetics of human longevity |
| Q34071528 | Common gene variants, mortality and extreme longevity in humans. |
| Q35860345 | Current status of efforts to measure and modulate the biological rate of aging |
| Q51544749 | Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians. |
| Q77351829 | Fibrinogen gene polymorphism in a non-Caucasian population |
| Q44040200 | Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians |
| Q32097099 | Genetic and environmental influences on exceptional longevity and the AGE nomogram |
| Q37214302 | Genetic epidemiology in aging research |
| Q34189907 | Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence |
| Q33378967 | Hemostasis and ageing. |
| Q91673577 | Hepatocyte gene expression and DNA methylation as ancestry-dependent mechanisms in African Americans |
| Q37041389 | Inflammaging as a prodrome to Alzheimer's disease |
| Q74755117 | Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians |
| Q46233388 | Lack of association of the plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly |
| Q59282945 | Leukocytes of exceptionally old persons display ultra-short telomeres |
| Q43915202 | Lipoprotein metabolism in Japanese centenarians: effects of apolipoprotein E polymorphism and nutritional status |
| Q34716106 | Living longer--but better? |
| Q36192488 | Molecular determinants of human longevity |
| Q74554779 | Paradoxes in longevity: sequence analysis of mtDNA haplogroup J in centenarians |
| Q44666871 | Parental longevity and mortality amongst Japanese men and women: the JACC Study |
| Q34217461 | Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions |
| Q28187014 | Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction |
| Q36494871 | Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants |
| Q46903118 | Reply to niermeijer |
| Q34159035 | Searching for human longevity genes: the future history of gerontology in the post-genomic era. |
| Q30841244 | The genetics of aging-- implications for pharmacogenomics |
| Q34655501 | The genetics of exceptional human longevity |
| Q37610388 | The hemostatic system through aging and menopause. |
| Q39544549 | The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism |
| Q74582774 | Under-representation of the -455A beta-fibrinogen allele in survivors of pulmonary embolism |
| Q34445966 | What does it take to live to 100? |
| Q37367277 | Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. |
Search more.